Essays about: "pharmaceutical abuse"

Showing result 1 - 5 of 19 essays containing the words pharmaceutical abuse.

  1. 1. The Guide: A Journey Through Holistic Healing

    University essay from Linnéuniversitetet/Institutionen för design (DE)

    Author : Stefan Johanson; [2021]
    Keywords : Holistic Medicine; Pharmaceutical Industry; War on Drugs; Hallucinogens; Narcotics; Healthcare System;

    Abstract : The Graphic Journalism genre is emerging with influences from war reportage with authors like Joe Sacco. I would like to address and report the “War on Drugs” from small first hand experiences, personal connections, and a genuine deep desire to see the healthcare and justice system change. READ MORE

  2. 2. EU Competition Law under Ordoliberalism - A case study of Excessive Pricing in Pharmaceutical Sector

    University essay from Malmö universitet/Fakulteten för kultur och samhälle (KS)

    Author : Ngoc Nha Tinh Tran; [2020]
    Keywords : Ordoliberalism; European Union; EU competition policy; excessive pricing; pharmaceutical industry; public health; pricing regulation; abuse of dominant positions;

    Abstract : The purpose of this study is to conceptualize the ideational influence of Ordoliberalism on EU Competition Law while addressing a problematic social issue that has been witnessing a surge in the number of cases, which is excessive price abuse under Article 102(a) of the Treaty on the Functioning of the European Union (TFEU) within the spectrum of pharmaceutical sector. By utilizing Nedergaard (2020)’s analytic framework for Ordoliberalism’s operationalization, the study successfully proves the impacts of five characteristics of Ordoliberalism, including Politics by rules, Economic Constitution, Market Construction, Role of Consumers and Role of the states towards consumers, on the practices of EU Competition Law, using the empirical data collected from two excessive pricing examples: Aspen in Italy and Pfizer/Flynn in the United Kingdom. READ MORE

  3. 3. Reverse payment settlements in the context of Article 102 TFEU: Abusive or not? By object or not?

    University essay from Lunds universitet/Juridiska institutionen

    Author : Julia Vahvaselkä; [2018]
    Keywords : Competition law; EU law; Abuse of a dominant position; Pharmaceutical industry; Settlements; Patents; Law and Political Science;

    Abstract : Pharmaceutical reverse payment settlements lie at the intersection of competition law and intellectual property law. In the recent years, these settlement agreements have increasingly attracted the attention of competition law authorities in the European Union. READ MORE

  4. 4. End of a blockbuster? – Preventing evergreening of pharmaceutical patents under EU competition law

    University essay from Lunds universitet/Juridiska institutionen

    Author : Maria Dürnel; [2017]
    Keywords : EU competition law; EU law; Article 102 TFEU; abuse of dominant position; evergreening; patent law; patent strategies; patents; pharmaceuticals; pharmaceutical industry; pharmaceutical sector inquiry; market definition; blockbuster drugs; generic competition; Law and Political Science;

    Abstract : The pharmaceutical industry is dependent on the granting of patents. Patents make it possible for pharmaceutical companies to invest in the necessary R&D to bring new drugs to the market. This benefits consumers and the health care sector at large. READ MORE

  5. 5. A Skinny Label - The intersection of EU competition law and patent law, and the abuse of dominance by the enforcement of second medical use patents

    University essay from Lunds universitet/Juridiska institutionen

    Author : Jenny Forsberg; [2016]
    Keywords : EU law; civil and criminal procedure; EU Competition Law; Article 102 TFEU; Abuse of dominance; Patent Law; Second medical use patent; Skinny labelling; Law and Political Science;

    Abstract : EU competition law is the safeguard of the functioning of the internal market, and not many fields of law other than patent law can delimit the scope of competition law. A patent’s value is based upon an exclusive right to the invention and product as protected by the patent. READ MORE